Stevens Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-16,117
| Closed | -$165K | – | 1224 |
|
|
2016
Q3 | $165K | Buy |
16,117
+4,173
| +35% | +$42.7K | 0.01% | 819 |
|
|
2016
Q2 | $156K | Buy |
+11,944
| New | +$156K | 0.01% | 805 |
|
|
2016
Q1 | – | Sell |
-20,194
| Closed | -$186K | – | 1231 |
|
|
2015
Q4 | $186K | Sell |
20,194
-631
| -3% | -$5.81K | 0.01% | 812 |
|
|
2015
Q3 | $145K | Sell |
20,825
-3,099
| -13% | -$21.6K | 0.01% | 869 |
|
|
2015
Q2 | $235K | Buy |
+23,924
| New | +$235K | 0.01% | 825 |
|
|
2014
Q2 | – | Sell |
-25,147
| Closed | -$114K | – | 1434 |
|
|
2014
Q1 | $114K | Sell |
25,147
-2,707
| -10% | -$12.3K | ﹤0.01% | 1002 |
|
|
2013
Q4 | $140K | Buy |
27,854
+4,161
| +18% | +$20.9K | ﹤0.01% | 949 |
|
|
2013
Q3 | $120K | Sell |
23,693
-15,003
| -39% | -$76K | ﹤0.01% | 964 |
|
|
2013
Q2 | $192K | Buy |
+38,696
| New | +$192K | 0.01% | 819 |
|